Signalling mechanisms linking hepatic glucose and lipid metabolism.
about
Methionine deficiency and hepatic injury in a dietary steatohepatitis modelAntidiabetic properties of dietary flavonoids: a cellular mechanism reviewPotential Bioactive Compounds from Seaweed for Diabetes ManagementImpact of postprandial glycaemia on health and prevention of diseaseNonmedicinal interventions in nonalcoholic fatty liver diseaseChronic alcohol consumption potentiates the development of diabetes through pancreatic β-cell dysfunctionER stress and hepatic lipid metabolism.Nuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice.Liver clock protein BMAL1 promotes de novo lipogenesis through insulin-mTORC2-AKT signalingQuantifying the improvement of surrogate indices of hepatic insulin resistance using complex measurement techniquesPioglitazone attenuates prostatic enlargement in diet-induced insulin-resistant rats by altering lipid distribution and hyperinsulinaemia.Integrative genomic analysis of CREB defines a critical role for transcription factor networks in mediating the fed/fasted switch in liver.MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease.Responses in gut microbiota and fat metabolism to a halogenated methane analogue in Sprague Dawley rats.Rhodiola crenulata extract regulates hepatic glycogen and lipid metabolism via activation of the AMPK pathwayCardiometabolic aspects of the polycystic ovary syndrome.Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals.Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators.Forkhead box transcription factor regulation and lipid accumulation by hepatitis C virus.Foods for the prevention of diabetes: how do they work?JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease.Prebiotics to manage the microbial control of energy homeostasis.Hepatic steatosis in type 1 diabetes.PXR cross-talks with internal and external signals in physiological and pathophysiological responses.Hepatitis C virus infection and insulin resistance.Hepatic miR-378 targets p110α and controls glucose and lipid homeostasis by modulating hepatic insulin signalling.Loss of Hepatic CEACAM1: A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver DiseaseFructose only in pregnancy provokes hyperinsulinemia, hypoadiponectinemia, and impaired insulin signaling in adult male, but not female, progeny.Responses to nutrients in farm animals: implications for production and quality.Alloxan-induced diabetes causes morphological and ultrastructural changes in rat liver that resemble the natural history of chronic fatty liver disease in humans.Impairment of fat oxidation under high- vs. low-glycemic index diet occurs before the development of an obese phenotype.TRAIL reduces impaired glucose tolerance and NAFLD in the high-fat diet fed mouse.PTP1B inhibitor improves both insulin resistance and lipid abnormalities in vivo and in vitro.Digestion rate of dietary starch affects the systemic circulation of lipid profiles and lipid metabolism-related gene expression in weaned pigs.A Thr94Ala mutation in human liver fatty acid-binding protein contributes to reduced hepatic glycogenolysis and blunted elevation of plasma glucose levels in lipid-exposed subjects
P2860
Q24650636-B0D6FB42-3F8B-4A07-B93E-572D3A58F38AQ26771961-32256FF2-E64C-41C4-9EAF-001D4A2E270BQ26797339-17AFDF71-CCAA-44BF-BBBD-04F6A0521E8BQ26862823-41D647CA-BCE5-4502-BC51-52AFFFE2F671Q26992054-51912E6C-E8C0-492C-A09F-809575CD3869Q28082228-01DA6123-3530-4557-A8A0-53184725ED1EQ33620277-93F6C27A-387B-4FBD-A0B5-537C76C05448Q33755271-CF24D824-38F6-4231-9942-54D90DC8FF0BQ34170848-CF687734-3B92-45F9-A9A7-8C8F017C8044Q34325851-9BDFA23B-D734-4A31-BE9D-6A3662572531Q34442391-6F878FEA-BBBD-4D46-8874-BA98BF0B39FAQ34727273-6C3F28E1-C33B-4924-ADBD-730F371BD2B0Q34750679-EB940FFC-672C-4DE2-B050-9C70B1CB8E18Q35533221-45B83F28-D54E-496E-9C33-89DF7027F59DQ36019201-B348D420-CFF5-4278-9C34-A89BFCD1BC81Q36287892-A9345D08-2EC7-430E-8DCA-DA9CE4BAB297Q37072370-2BD843EC-6BBA-4F58-9C23-4B9B74A6A45CQ37352636-90944EDA-CFEF-4FA8-8719-EAF22BB5E493Q37713887-5BDFB03A-282B-4405-9FA2-D7456D635725Q37893104-2A0DFF98-501F-4159-A04A-E40AC06A4D7FQ37944211-09679DAF-87D2-4EA1-9482-A079DB9024D2Q37965353-94FF89CD-F45B-4EE9-86E9-BDBE093C6155Q38009669-BCE7A5D9-C767-4B03-A685-D5591EF5382EQ38108791-0C6377DE-C768-4F1E-B6DE-195E14CD9C18Q38190958-615DEDF1-BF32-4A68-8E08-59F009F35750Q38302507-CE94528D-C3F8-4050-B6AE-5ABD7531A973Q39128964-13DFA8E3-C17E-41D5-87B3-58B7260119EDQ42175294-0C3C69FC-6D48-4A34-A30B-662698C05964Q42719842-2F724392-6611-4922-BE86-67D0FE38D90BQ43177845-4B90B433-F981-4822-B12A-40FA78B89C56Q43236613-2248BACD-2C7A-4DD4-A766-F82FA9527C95Q47372528-95B10E8B-35F4-4630-BE7E-8EC283525FD9Q50535633-09AB38E4-B22B-4EFE-B7EC-9279E6007B7DQ51606591-C5B20DC6-ACA8-4A8B-AD01-64FC361FD530Q56987585-F9C149BB-0E23-4DF5-85B4-87FDD7A2B40B
P2860
Signalling mechanisms linking hepatic glucose and lipid metabolism.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Signalling mechanisms linking hepatic glucose and lipid metabolism.
@ast
Signalling mechanisms linking hepatic glucose and lipid metabolism.
@en
type
label
Signalling mechanisms linking hepatic glucose and lipid metabolism.
@ast
Signalling mechanisms linking hepatic glucose and lipid metabolism.
@en
prefLabel
Signalling mechanisms linking hepatic glucose and lipid metabolism.
@ast
Signalling mechanisms linking hepatic glucose and lipid metabolism.
@en
P2860
P1433
P1476
Signalling mechanisms linking hepatic glucose and lipid metabolism.
@en
P2093
A F H Pfeiffer
M O Weickert
P2860
P2888
P304
P356
10.1007/S00125-006-0295-3
P577
2006-05-23T00:00:00Z